Employment status in cancer patients the first five years after diagnosis-a register-based study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cancer survivors often face employment challenges, with most cancer types impacting work status up to five years post-diagnosis. Some diagnoses present persistent work difficulties, necessitating targeted support for cancer patients returning to work.
Area Of Science
- Oncology
- Epidemiology
- Occupational Health
Background
- Work is crucial for identity, social standing, and financial independence.
- Existing research on cancer survivorship and employment is limited, with no comprehensive analysis across all cancer types.
Purpose Of The Study
- To investigate the impact of all cancer diagnoses on employment status.
- To compare employment outcomes between cancer patients and cancer-free individuals.
Main Methods
- A cohort study included 111,770 Danish cancer patients (aged 20-60) diagnosed between 2000-2015.
- Patients were matched 1:5 with 507,003 cancer-free controls.
- Logistic and linear regression analyzed work status and participation at one, three, and five years post-diagnosis across 11 cancer types.
Main Results
- All cancer types showed reduced employment chances one year post-diagnosis (ORs 0.05-0.76).
- Lung, colorectal, upper gastrointestinal, and blood cancers had the lowest employment rates.
- After three years, 10 of 11 cancer types had lower employment chances (ORs 0.39-0.84); by five years, differences were minimal for most types (ORs 0.75-1.36).
Conclusions
- Most cancer patients experienced diminished employment opportunities for up to five years post-diagnosis.
- Certain cancer types were associated with persistently lower employment chances, despite gradual improvement.
- Findings highlight the need for increased awareness and targeted vocational rehabilitation for cancer survivors.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...